Position in ASND
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,302,388
New position
Shares Held
5,694
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vinva Investment Management Ltd holds $66,411,479 across 13 Biotechnology names. ASND ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
300,405 | $28,274,118 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
36,601 | $12,110,172 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,862 | $11,482,975 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,531 | $4,255,972 | |
| 5 | EXEL |
Exelixis, Inc.
|
49,204 | $2,110,359 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
11,142 | $2,106,395 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
32,126 | $2,076,303 | |
| 8 | ASND |
Ascendis Pharma A/S
This page
|
5,694 | $1,302,388 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,302,388 | 5,694 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||